Sign in
4

Changes in Ownership

PROTHENA CORP PUBLIC LTD CO Filed Acc 0000905148-24-000841

Options or other derivatives

  • Chief Scientific Officer acquired 85,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Zago Wagner M. Chief Scientific Officer 2024-02-27 Grant or award · Stock Option (Right to Buy) +85,000 85,000 D: show line 1 in the form
Loading xslF345X05/form4.xml…